Literature DB >> 21248494

Determination of factors affecting glutamate concentrations in the whole blood of healthy human volunteers.

Alexander Zlotnik1, Sharon Ohayon, Benjamin F Gruenbaum, Shaun E Gruenbaum, Boaz Mohar, Matthew Boyko, Yael Klin, Eyal Sheiner, Gad Shaked, Yoram Shapira, Vivian I Teichberg.   

Abstract

BACKGROUND: Abnormally high concentrations of glutamate in brain fluids have been shown to be neurotoxic and correlate with a poor neurological outcome following traumatic brain injury (TBI). Since brain fluid glutamate can be reduced by scavenging blood glutamate, the purpose of this study was to investigate factors that may potentially influence levels of blood glutamate, glucose, and the enzymes glutamate-pyruvate transaminase (GPT) and glutamate-oxaloacetate transaminase (GOT) in healthy individuals.
METHODS: Factors that were examined included age, gender, time of last meal or drink, and recent consumption of coffee. A total of 112 healthy volunteers between 18 and 70 years of age participated in the study. The average participant was 38 years old, and the sample consisted of 48 males and 64 females. Five milliliters of venous blood was collected from participants' cubital vein and blood glutamate, glucose, GOT and GPT levels were determined. Participants were then asked to complete a questionnaire addressing their gender, age, time of last meal, time of last drink, and whether coffee was consumed within the last 6 hours.
RESULTS: Blood glutamate concentrations were significantly higher in males than in females (P < 0.001) and may be due to effects of estrogen and progesterone. Concentrations of GOT were significantly higher in males than in females (P < 0.01). Concentrations of GPT were significantly higher in males than in females (P < 0.01). There were no other significant differences demonstrated.
CONCLUSIONS: Understanding the factors that affect blood glutamate levels may give new insight into mechanisms that protect the brain from excess glutamate and result in a better neurological outcome following TBI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248494     DOI: 10.1097/ANA.0b013e3181f82a8f

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  17 in total

1.  Expression of Glutamate Transporters in Mouse Liver, Kidney, and Intestine.

Authors:  Qiu Xiang Hu; Sigrid Ottestad-Hansen; Silvia Holmseth; Bjørnar Hassel; Niels Christian Danbolt; Yun Zhou
Journal:  J Histochem Cytochem       Date:  2018-01-05       Impact factor: 2.479

2.  Some amino acids levels: glutamine,glutamate, and homocysteine, in plasma of children with chronic kidney disease.

Authors:  Fatina I Fadel; Manal F Elshamaa; Rascha G Essam; Eman A Elghoroury; Gamila S M El-Saeed; Safinaz E El-Toukhy; Mona Hamed Ibrahim
Journal:  Int J Biomed Sci       Date:  2014-03

3.  Blood Glutamate Reducing Effect of Hemofiltration in Critically Ill Patients.

Authors:  Evgeni Brotfain; Ruslan Kutz; Julia Grinshpun; Benjamin F Gruenbaum; Shaun E Gruenbaum; Amit Frenkel; Agzam Zhumadilov; Vladimir Zeldetz; Yoav Bichovsky; Matthew Boyko; Moti Klein; Alexander Zlotnik
Journal:  Neurotox Res       Date:  2017-08-23       Impact factor: 3.911

4.  Effect of estrogens on blood glutamate levels in relation to neurological outcome after TBI in male rats.

Authors:  Alexander Zlotnik; Akiva Leibowitz; Boris Gurevich; Sharon Ohayon; Matthew Boyko; Moti Klein; Boris Knyazer; Yoram Shapira; Vivian I Teichberg
Journal:  Intensive Care Med       Date:  2011-11-29       Impact factor: 17.440

Review 5.  Sex as a biological variable in the pathology and pharmacology of neurodegenerative and neurovascular diseases.

Authors:  Pedram Honarpisheh; Louise D McCullough
Journal:  Br J Pharmacol       Date:  2019-05-21       Impact factor: 8.739

6.  Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice.

Authors:  Yun Zhou; Leonie F Waanders; Silvia Holmseth; Caiying Guo; Urs V Berger; Yuchuan Li; Anne-Catherine Lehre; Knut P Lehre; Niels C Danbolt
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

7.  Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naïve rats.

Authors:  Matthew Boyko; David Stepensky; Benjamin F Gruenbaum; Shaun E Gruenbaum; Israel Melamed; Sharon Ohayon; Michael Glazer; Yoram Shapira; Alexander Zlotnik
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

Review 8.  Brain to blood glutamate scavenging as a novel therapeutic modality: a review.

Authors:  Matthew Boyko; Shaun E Gruenbaum; Benjamin F Gruenbaum; Yoram Shapira; Alexander Zlotnik
Journal:  J Neural Transm (Vienna)       Date:  2014-03-13       Impact factor: 3.575

9.  Relationship between psychological stress and metabolism in morbidly obese individuals.

Authors:  Friedrich Riffer; Manuel Sprung; Hannah Münch; Elmar Kaiser; Lore Streibl; Kathrin Heneis; Alexandra Kautzky-Willer
Journal:  Wien Klin Wochenschr       Date:  2019-12-09       Impact factor: 1.704

Review 10.  Blood glutamate scavenging: insight into neuroprotection.

Authors:  Akiva Leibowitz; Matthew Boyko; Yoram Shapira; Alexander Zlotnik
Journal:  Int J Mol Sci       Date:  2012-08-13       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.